FDA Warning Letter — National Chemical Laboratories

Case 662110 — FEI 1000071237

The FDA took a Warning Letter action against National Chemical Laboratories on November 8, 2023 (Philadelphia, PA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
National Chemical Laboratories
Date
November 8, 2023
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Philadelphia, PA (United States)